Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.4K Hold
823
0.01% 327
2025
Q4
$40.4K Hold
823
0.01% 305
2025
Q3
$35.5K Hold
823
0.01% 295
2025
Q2
$31.6K Hold
823
0.01% 280
2025
Q1
$31.9K Hold
823
0.01% 239
2024
Q4
$27.8K Hold
823
0.01% 240
2024
Q3
$33.6K Sell
823
-11,473
-93% -$469K 0.02% 205
2024
Q2
$473K Buy
+12,296
New +$517K 0.29% 34

Other funds holding GSK

Dunhill Financial's GSK Position: Q1 2026 in Review

Dunhill Financial held its GSK (GSK) position steady in Q1 2026 at 823 shares worth $45.4K. The position accounts for 0.01% of the portfolio, ranked #327.

Dunhill Financial first reported a position in GSK in Q2 2024 and has held it in 8 quarters since. The position peaked at $473K in Q2 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Dunhill Financial held 823 shares of GSK worth $45.4K as of Q1 2026.
  • Dunhill Financial left its GSK share count unchanged in Q1 2026.
  • GSK made up 0.01% of Dunhill Financial's portfolio in Q1 2026, its #327 holding.
  • Dunhill Financial first reported a position in GSK in Q2 2024 and has held it in 8 quarters since.
  • Dunhill Financial's GSK position peaked at $473K in Q2 2024.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.